1219794-69-0

1219794-69-0 structure

Name: Phenylbutazone(diphenyl-d10)
Chemical Name: Phenylbutazone(diphenyl-d10)
CAS Number: 1219794-69-0
Molecular Formula: C₁₉H₁₀D₁₀N₂O₂
Molecular Weight: 318.44
Catalog: Signaling Pathways Immunology/Inflammation COX
Create Date: 2021-10-24 18:17:25
Modify Date: 2024-01-10 02:25:10
Phenylbutazone-d10 (diphenyl) is the deuterium labeled Phenylbutazone. Phenylbutazone is an efficient reducing cofactor for the peroxidase activity of prostaglandin H synthase (PHS). Phenylbutazone, a hepatotoxin, is a nonsteroidal anti-inflammatory drug (NSAID). Phenylbutazone induces muscle blind-like protein 1 (MBNL1) expression and has the potential for ankylosing spondylitis research[1][2].

Name	Phenylbutazone(diphenyl-d10)

Description	Phenylbutazone-d10 (diphenyl) is the deuterium labeled Phenylbutazone. Phenylbutazone is an efficient reducing cofactor for the peroxidase activity of prostaglandin H synthase (PHS). Phenylbutazone, a hepatotoxin, is a nonsteroidal anti-inflammatory drug (NSAID). Phenylbutazone induces muscle blind-like protein 1 (MBNL1) expression and has the potential for ankylosing spondylitis research[1][2].
Related Catalog	Research Areas >> Inflammation/Immunology Signaling Pathways >> Immunology/Inflammation >> COX
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. G A Reed, et al. Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone. Requirement for peroxidative metabolism. Mol Pharmacol. 1985 Jan;27(1):109-14. [3]. Guiying Chen, et al. Phenylbutazone induces expression of MBNL1 and suppresses formation of MBNL1-CUG RNA foci in a mouse model of myotonic dystrophy. Sci Rep. 2016 Apr 29;6:25317. [4]. Beretta C, et al. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis. Pharmacol Res. 2005 Oct;52(4):302-6.

Molecular Formula	C₁₉H₁₀D₁₀N₂O₂
Molecular Weight	318.44

1219794-69-0	65854-97-9
37055-51-9	93951-92-9
1325559-13-4	1486-01-7
4297-92-1	129-18-0
50-33-9	65651-04-9
2097930-77-1	1227573-07-0
1848252-63-0	1158522-08-7
940364-43-2	1333252-46-2
134104-43-1	131615-57-1
6906-52-1	930439-75-1